logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9408907 B1

PDFFull Text
Date of Patent:
Aug. 09, 2016

Filed:

Dec. 15, 2010

Homogenous suspension of immunopotentiating compounds and uses thereof

Applicants:

David Skibinski, Singapore, SG;

Siddhartha Jain, Irvine, CA (US);

Manmohan Singh, Lexington, MA (US);

Derek O'hagan, Winchester, MA (US);

Inventors:

David Skibinski, Singapore, SG;

Siddhartha Jain, Irvine, CA (US);

Manmohan Singh, Lexington, MA (US);

Derek O'Hagan, Winchester, MA (US);

Assignee:

GlaxoSmithKline Biologicals SA, Rixensart, BE;

Attorneys:

Helen Lee

Virginia Campen

Primary Examiner:

Johann R Richter

Assistant Examiner:

Yanzhi Zhang

Int. Cl.
CPC ...
A61K 39/39 (2006.01); A61K 31/4745 (2006.01); A61K 31/7004 (2006.01); A61K 31/717 (2006.01); A61K 39/095 (2006.01); A61K 39/155 (2006.01); A61K 31/496 (2006.01); A61K 31/5377 (2006.01); A61K 31/675 (2006.01); A61K 31/683 (2006.01); A61K 39/12 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/39 (2013.01); A61K 31/4745 (2013.01); A61K 31/496 (2013.01); A61K 31/5377 (2013.01); A61K 31/675 (2013.01); A61K 31/683 (2013.01); A61K 31/7004 (2013.01); A61K 31/717 (2013.01); A61K 39/095 (2013.01); A61K 39/12 (2013.01); A61K 39/155 (2013.01); A61K 2039/55505 (2013.01); A61K 2039/55511 (2013.01); A61K 2039/55555 (2013.01); A61K 2039/55561 (2013.01); A61K 2039/55566 (2013.01); C12N 2760/18534 (2013.01);
Abstract

The present invention generally relates to homogeneous suspensions of small molecule immune potentiators (SMIPs) that are capable of stimulating or modulating an immune response in a subject in need thereof. The homogeneous suspensions may be used in combinations with various antigens or adjuvants for vaccine therapies.

Find Patent Forward Citations

Skibinski, David. (2016). Homogenous suspension of immunopotentiating compounds and uses thereof (U.S. Patent No. 9408907). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9408907

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…